These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 32336148

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.
    Gracies JM, Esquenazi A, Brashear A, Banach M, Kocer S, Jech R, Khatkova S, Benetin J, Vecchio M, McAllister P, Ilkowski J, Ochudlo S, Catus F, Grandoulier AS, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Lower Limb Spasticity Study Group.
    Neurology; 2017 Nov 28; 89(22):2245-2253. PubMed ID: 29093068
    [Abstract] [Full Text] [Related]

  • 4. Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis.
    McAllister PJ, Khatkova SE, Faux SG, Picaut P, Raymond R, Gracies JM.
    J Rehabil Med; 2019 Oct 29; 51(10):813-816. PubMed ID: 31529136
    [Abstract] [Full Text] [Related]

  • 5. Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study.
    O'Dell MW, Brashear A, Jech R, Lejeune T, Marque P, Bensmail D, Ayyoub Z, Simpson DM, Volteau M, Vilain C, Picaut P, Gracies JM.
    PM R; 2018 Jan 29; 10(1):1-10. PubMed ID: 28634000
    [Abstract] [Full Text] [Related]

  • 6. Validity and reliability of the chronic composite XA, an upper limb motor assessment using Active Range of Motion in patients with chronic stroke.
    Jamal K, Butet S, Maitre B, Gracies JM, Hameau S, Leveque LE Bras É, Baude M, Cordillet S, Bonan I.
    Eur J Phys Rehabil Med; 2024 Aug 29; 60(4):559-566. PubMed ID: 38958692
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
    Gracies JM, O'Dell M, Vecchio M, Hedera P, Kocer S, Rudzinska-Bar M, Rubin B, Timerbaeva SL, Lusakowska A, Boyer FC, Grandoulier AS, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Muscle Nerve; 2018 Feb 29; 57(2):245-254. PubMed ID: 28590525
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
    Gracies JM, Jech R, Valkovic P, Marque P, Vecchio M, Denes Z, Vilain C, Delafont B, Picaut P.
    Brain Commun; 2021 Feb 29; 3(1):fcaa201. PubMed ID: 33543139
    [Abstract] [Full Text] [Related]

  • 11. Spasticity and Range of Motion Over Time in Stroke Patients Who Received Multiple-Dose Botulinum Toxin Therapy.
    Ro T, Ota T, Saito T, Oikawa O.
    J Stroke Cerebrovasc Dis; 2020 Jan 29; 29(1):104481. PubMed ID: 31699575
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect on Passive Range of Motion and Functional Correlates After a Long-Term Lower Limb Self-Stretch Program in Patients With Chronic Spastic Paresis.
    Pradines M, Baude M, Marciniak C, Francisco G, Gracies JM, Hutin E, Bayle N.
    PM R; 2018 Oct 29; 10(10):1020-1031. PubMed ID: 29505896
    [Abstract] [Full Text] [Related]

  • 15. The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury.
    Esquenazi A, Brashear A, Deltombe T, Rudzinska-Bar M, Krawczyk M, Skoromets A, O'Dell MW, Grandoulier AS, Vilain C, Picaut P, Gracies JM.
    PM R; 2021 May 29; 13(5):488-495. PubMed ID: 32741133
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of repetitive peripheral magnetic stimulation on upper-limb spasticity and impairment in patients with spastic hemiparesis: a randomized, double-blind, sham-controlled study.
    Krewer C, Hartl S, Müller F, Koenig E.
    Arch Phys Med Rehabil; 2014 Jun 29; 95(6):1039-47. PubMed ID: 24561057
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
    Hameau S, Bensmail D, Robertson J, Boudarham J, Roche N, Zory R.
    Eur J Phys Rehabil Med; 2014 Oct 29; 50(5):515-23. PubMed ID: 24651151
    [Abstract] [Full Text] [Related]

  • 20. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP.
    Clin Rehabil; 2002 Sep 29; 16(6):654-60. PubMed ID: 12392341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.